Viewing StudyNCT00085709



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00085709
Status: COMPLETED
Last Update Posted: 2015-09-30
First Post: 2004-06-14

Brief Title: S0106 Cytarabine and Daunorubicin w or wo Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
Sponsor: SWOG Cancer Research Network
Organization: SWOG Cancer Research Network

Organization Data

Organization: SWOG Cancer Research Network
Class: NETWORK
Study ID: S0106
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: SWOG Cancer Research Network
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH